419 related articles for article (PubMed ID: 23228154)
1. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
[TBL] [Abstract][Full Text] [Related]
2. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
[TBL] [Abstract][Full Text] [Related]
5. Falcipain-2 inhibitors.
Ettari R; Bova F; Zappalà M; Grasso S; Micale N
Med Res Rev; 2010 Jan; 30(1):136-67. PubMed ID: 19526594
[TBL] [Abstract][Full Text] [Related]
6. Malarial protease inhibitors: potential new chemotherapeutic agents.
Sharma A
Curr Opin Investig Drugs; 2007 Aug; 8(8):642-52. PubMed ID: 17668366
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of small molecular dual inhibitor of falcipain-2 and dihydrofolate reductase as antimalarial agent.
Huang H; Lu W; Li X; Cong X; Ma H; Liu X; Zhang Y; Che P; Ma R; Li H; Shen X; Jiang H; Huang J; Zhu J
Bioorg Med Chem Lett; 2012 Jan; 22(2):958-62. PubMed ID: 22192590
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
[TBL] [Abstract][Full Text] [Related]
9. Cysteine proteases of malaria parasites.
Rosenthal PJ
Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
[TBL] [Abstract][Full Text] [Related]
10. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
Teixeira C; Gomes JR; Gomes P
Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
[TBL] [Abstract][Full Text] [Related]
11. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
[TBL] [Abstract][Full Text] [Related]
12. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
Rosenthal PJ; Lee GK; Smith RE
J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
[TBL] [Abstract][Full Text] [Related]
14. An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites.
Oliveira R; Newton AS; Guedes RC; Miranda D; Amewu RK; Srivastava A; Gut J; Rosenthal PJ; O'Neill PM; Ward SA; Lopes F; Moreira R
ChemMedChem; 2013 Sep; 8(9):1528-36. PubMed ID: 23853126
[TBL] [Abstract][Full Text] [Related]
15. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
[TBL] [Abstract][Full Text] [Related]
16. Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum.
Bertoldo JB; Chiaradia-Delatorre LD; Mascarello A; Leal PC; Cordeiro MN; Nunes RJ; Sarduy ES; Rosenthal PJ; Terenzi H
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):299-307. PubMed ID: 24964346
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel parasitic cysteine protease inhibitors using virtual screening. 1. The ChemBridge database.
Desai PV; Patny A; Sabnis Y; Tekwani B; Gut J; Rosenthal P; Srivastava A; Avery M
J Med Chem; 2004 Dec; 47(26):6609-15. PubMed ID: 15588096
[TBL] [Abstract][Full Text] [Related]
18. Small molecule anti-malarial patents: a review (January 2010-June 2011).
Svennas KL; Macdonald SJ; Willis PA
Expert Opin Ther Pat; 2012 Jun; 22(6):607-43. PubMed ID: 22694759
[TBL] [Abstract][Full Text] [Related]
19. The impact of whole genome sequence data on drug discovery--a malaria case study.
Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
